dx.doi.org/10.1093/annonc/mdy284.026, hdl.handle.net/1765/125534
Annals of Oncology
Erasmus University Rotterdam

Westgeest, H.M, Kuppen, M. (M.), van den Eertwegh, A.J.M, Van Moorselaar, J. (J.), Mehra, N. (N.), van Oort, I.M, … Gerritsen, W.R. (2018). Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI: An observational study in the Netherlands. Annals of Oncology, 29, viii283–viii284. doi:10.1093/annonc/mdy284.026